{"count":4,"next":null,"previous":null,"results":[{"gene_data":{"alias":["p180"],"biotype":"protein_coding","hgnc_id":"HGNC:9173","gene_name":"DNA polymerase alpha 1, catalytic subunit","omim_gene":["312040"],"alias_name":null,"gene_symbol":"POLA1","hgnc_symbol":"POLA1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:24712036-25015103","ensembl_id":"ENSG00000101868"}},"GRch38":{"90":{"location":"X:24693919-24996986","ensembl_id":"ENSG00000101868"}}},"hgnc_date_symbol_changed":"2006-09-26"},"entity_type":"gene","entity_name":"POLA1","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":null,"publications":["15844784","27019227","19377476"],"evidence":["Expert Review Amber","Literature"],"phenotypes":["Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220","XLPDR"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":["non-coding-known-pathogenic"],"panel":{"id":255,"hash_id":"57c5b45b8f62030d5014a949","name":"Neurofibromatosis Type 1","disease_group":"Tumour syndromes","disease_sub_group":"Muscle and nerve","status":"public","version":"1.26","version_created":"2019-06-20T15:13:27.332971Z","relevant_disorders":[],"stats":{"number_of_genes":30,"number_of_strs":0,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["p180"],"biotype":"protein_coding","hgnc_id":"HGNC:9173","gene_name":"DNA polymerase alpha 1, catalytic subunit","omim_gene":["312040"],"alias_name":null,"gene_symbol":"POLA1","hgnc_symbol":"POLA1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:24712036-25015103","ensembl_id":"ENSG00000101868"}},"GRch38":{"90":{"location":"X:24693919-24996986","ensembl_id":"ENSG00000101868"}}},"hgnc_date_symbol_changed":"2006-09-26"},"entity_type":"gene","entity_name":"POLA1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":null,"publications":["27019227"],"evidence":["NHS GMS","North West GLH","London North GLH","Expert Review Green","IUIS Classification February 2018"],"phenotypes":["Hyperpigmentation, characteristic facies, lung and GI involvement","Autoinflammatory Disorders","Pigmentary disorder, reticulate, with systemic manifestations, X-linked 301220","X-linked reticulate pigmentary disorder","x-linked cutaneous amyloidosis with systemic features"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":398,"hash_id":null,"name":"Primary immunodeficiency","disease_group":"","disease_sub_group":"","status":"public","version":"1.132","version_created":"2019-09-27T14:37:49.085568Z","relevant_disorders":["Primary immunodeficiency disorders","A- or hypo-gammaglobulinaemia","Congenital neutropaenia","Agranulocytosis","Combined B and T cell defect","Inherited complement deficiency","SCID","Primary immune disorder","Primary immunodeficiency","A-gammaglobulinaemia","Agammaglobulinaemia","hypo-gammaglobulinaemia","hypogammaglobulinemia","immune deficiency syndromes","Severe combined immunodeficiency","Congenital neutopenia","Familial haemophagocytic lymphohistiocytic disorders","Familial hemophagocytic lymphohistiocytic disorders","PID","Sepsis","Disseminated non-tuberculous mycobacterial infection","R15"],"stats":{"number_of_genes":395,"number_of_strs":0,"number_of_regions":2},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["p180"],"biotype":"protein_coding","hgnc_id":"HGNC:9173","gene_name":"DNA polymerase alpha 1, catalytic subunit","omim_gene":["312040"],"alias_name":null,"gene_symbol":"POLA1","hgnc_symbol":"POLA1","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"X:24712036-25015103","ensembl_id":"ENSG00000101868"}},"GRch38":{"90":{"location":"X:24693919-24996986","ensembl_id":"ENSG00000101868"}}},"hgnc_date_symbol_changed":"2006-09-26"},"entity_type":"gene","entity_name":"POLA1","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["31006512"],"evidence":["Expert Review Green","DD-Gene2Phenotype"],"phenotypes":["VAN ESCH-O'DRISCOLL SYNDROME 301030"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":484,"hash_id":null,"name":"DDG2P","disease_group":"","disease_sub_group":"","status":"public","version":"1.137","version_created":"2019-10-08T15:56:59.220133Z","relevant_disorders":[],"stats":{"number_of_genes":1893,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["p180"],"biotype":"protein_coding","hgnc_id":"HGNC:9173","gene_name":"DNA polymerase alpha 1, catalytic subunit","omim_gene":["312040"],"alias_name":null,"gene_symbol":"POLA1","hgnc_symbol":"POLA1","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"X:24712036-25015103","ensembl_id":"ENSG00000101868"}},"GRch38":{"90":{"location":"X:24693919-24996986","ensembl_id":"ENSG00000101868"}}},"hgnc_date_symbol_changed":"2006-09-26"},"entity_type":"gene","entity_name":"POLA1","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["15844784","27019227","19377476","31006512"],"evidence":["Expert Review Green"],"phenotypes":["Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220","XLPDR","X-Linked Intellectual Disability associated with short stature, microcephaly, and hypogonadism"],"mode_of_inheritance":"X-LINKED: hemizygous mutation in males, biallelic mutations in females","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}}]}